EMEA-002862-PIP01-20-M01

Table of contents

Key facts

Invented name
Vaxzevria (previously COVID-19 Vaccine AstraZeneca)
Active substance
COVID-19 vaccine (ChAdOx1-S [recombinant]) (AZD1222)
Therapeutic area
Vaccines
Decision number
P/0266/2021
PIP number
EMEA-002862-PIP01-20-M01
Pharmaceutical form(s)
Suspension for injection
Condition(s) / indication(s)
Prevention of Coronavirus disease 2019 (COVID-19)
Route(s) of administration
Intramuscular use
Contact for public enquiries
AstraZeneca AB

Tel.  +46 855324400

E-mail: paediatrics@astrazeneca.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

Related content

How useful was this page?

Add your rating
Average
4 ratings
1 rating
4 ratings
13 ratings